Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-008074
Filing Date
2019-02-14
Accepted
2019-02-14 16:01:30
Documents
2
Group Members
JEREMY C. GREEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv513369_sc13g.htm SC 13G 68597
2 EXHIBIT 99.1 tv513369_ex99-1.htm EX-99.1 4424
  Complete submission text file 0001144204-19-008074.txt   74596
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87481 | Film No.: 19605835
SIC: 2834 Pharmaceutical Preparations